Celularity Inc.
CELU
$1.66
-$0.01-0.60%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 145.54% | 312.22% | 273.09% | 193.34% | -8.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 145.54% | 312.22% | 273.09% | 193.34% | -8.44% |
| Cost of Revenue | 7.80% | 164.71% | -18.12% | 83.13% | -50.06% |
| Gross Profit | 2,841.85% | 367.60% | 575.00% | 323.88% | 105.98% |
| SG&A Expenses | 17.70% | 24.02% | 0.67% | -31.51% | -27.90% |
| Depreciation & Amortization | -32.19% | -16.48% | 0.92% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.67% | -2.16% | -34.02% | -36.00% | -53.32% |
| Operating Income | 29.28% | 48.71% | 74.99% | 65.83% | 58.09% |
| Income Before Tax | 82.85% | 86.47% | 65.61% | -60.91% | -2,063.11% |
| Income Tax Expenses | -- | -- | -- | -23.08% | -- |
| Earnings from Continuing Operations | 82.85% | 86.47% | 65.61% | -60.93% | -2,056.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.85% | 86.47% | 65.61% | -60.93% | -2,056.16% |
| EBIT | 29.28% | 48.71% | 74.99% | 65.83% | 58.09% |
| EBITDA | 30.98% | 53.31% | 80.76% | 70.82% | 61.76% |
| EPS Basic | 85.31% | 89.07% | 75.08% | -70.22% | -1,581.87% |
| Normalized Basic EPS | -23.56% | 78.80% | 74.68% | 136.76% | 70.28% |
| EPS Diluted | 85.31% | 89.07% | 75.08% | -61.26% | -1,761.67% |
| Normalized Diluted EPS | -23.56% | 78.80% | 74.68% | 146.73% | 68.64% |
| Average Basic Shares Outstanding | 16.70% | 23.75% | 38.00% | 31.21% | 31.99% |
| Average Diluted Shares Outstanding | 16.70% | 23.75% | 38.00% | 3.20% | 25.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |